NEW YORK, Oct. 7, 2014 /PRNewswire/ -- The Law Offices of
Vincent Wong are investigating
potential claims against the Board of Directors of Durata
Therapeutics Inc. (Nasdaq: DRTX) ("Durata") in connection with the
sale of the Company to Actavis (NYSE: ACT).
Click here to learn about the case:
http://docs.wongesq.com/DRTX-Info-Request-Form-431. There is
no cost or obligation to you.
Under the terms of the transaction, Durata shareholders will
receive $23.00 in cash for each share
of Durata common stock they own, as well as contingent value rights
entitling the holder to additional cash payments of up to
$5.00 per share upon the achievement
of particular milestones. The investigation concerns whether the
Board of Durata breached their fiduciary duty to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Actavis is underpaying for
Durata shares.
If you own common stock in Durata and wish to obtain additional
information, please contact Vincent Wong,
Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit
http://docs.wongesq.com/DRTX-Info-Request-Form-431.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
SOURCE The Law Offices of Vincent
Wong